- Hancock County Savings Bank Charitable Foundation celebrates 25 years | News, Sports, Jobs
- CT’s College Savings Program Earns Ratings Upgrade — Connecticut by the Numbers
- How To Maximize Your Savings By Effectively Using Your Bank’s Budgeting Apps
- A Word in Support of Daylight Savings
- How a Journalist Went From Exposing Mexican Cartels to Losing His Crypto Life Savings
Couzin-Frankel J. Obesity meets its match: blockbuster weight loss drugs show promise for a wider range of health benefits. Science. 2023;382:1227.
Bạn đang xem: Anti-obesity medication patients’ self-reported food savings versus the cost of such medicines
Rubino D, Abrahamsson N, Davies M, Hesse D, Greenway FL, Jensen C, et al. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial. JAMA. 2021;325:1414–25.
Liu BY, Rome BN. State Coverage and Reimbursement of Antiobesity Medications in Medicaid. JAMA. 2024;331:1230–1.
Cawley J, Biener A, Meyerhoefer C, Ding Y, Zvenyach T, Smolarz BG, et al. Direct medical costs of obesity in the United States and the most populous states. J Manag Care Spec Pharm. 2021;27:354–66.
Trogdon JG, Finkelstein EA, Hylands T, Dellea PS, Kamal‐Bahl SJ. Indirect costs of obesity: a review of the current literature. Obes Rev. 2008;9:489–500.
Xem thêm : Trump proposes ending daylight saving time, something OK voted to make permanent
Withrow D, Alter DA. The economic burden of obesity worldwide: a systematic review of the direct costs of obesity. Obes Rev. 2011;12:131–41.
Blundell J, Finlayson G, Axelsen M, Flint A, Gibbons C, Kvist T, et al. Effects of once‐weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity. Diabetes Obes Metab. 2017;19:1242–51.
Friedrichsen M, Breitschaft A, Tadayon S, Wizert A, Skovgaard D. The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity. Diabetes Obes Metab. 2021;23:754–62.
Heise T, DeVries JH, Urva S, Li J, Pratt EJ, Thomas MK, et al. Tirzepatide reduces appetite, energy intake, and fat mass in people with type 2 diabetes. Diabetes Care. 2023;46:998–1004.
Peck E. How weight loss drugs like Ozempic could radically reshape the food business. Axios, Oct, 2023. Accessed May 3, 2024. https://www.axios.com/2023/10/06/ozempic-weight-loss-drugs-food-business.
Bettadapura S, Dowling K, Jablon K, Al-Humadi AW & le Roux CW. Changes in food preferences and ingestive behaviors after glucagon-like peptide-1 analog treatment: techniques and opportunities. Int J Obes. 2024 (Mar 7);1–9.
Xem thêm : Socure calculates major savings from reduced false positives in AML screening
U.S. Bureau of Labor Statistics. Consumer Expenditure Surveys. Undated. Accessed April 20, 2024. https://www.bls.gov/cex/.
Green L, Taddei-Allen P. Shifting paradigms: reframing coverage of antiobesity medications for plan sponsors. J Manag Care Spec Pharm. 2023;29:564–8.
Nguyen T, Wong E, Cope R. Evaluating the efficacy and pharmacoeconomics of semaglutide and tirzepatide in the setting of obesity. Am J Ther. 2023;30:e347–52.
Levi J, Wang J, Venter F, Hill A. Estimated minimum prices and lowest available national prices for antiobesity medications: improving affordability and access to treatment. Obes (Silver Spring). 2023;31:1270–9.
U.S. Bureau of Labor Statistics. Consumer Price Index for All Urban Consumers: Food in U.S. City Average. Accessed May, 2024. https://fred.stlouisfed.org/series/CPIUFDNS.
Guzman G, Kollar M. Income in the United States: 2022. U.S. Census Bureau, Current Population Reports, P60-279. U.S. Government Publishing Office, Washington, DC, Sep 2023.
Lieberman DA. State of Obesity 2021: Better Policies for a Healthier America. Trust for America’s Health. 2021. Accessed May, 2024. https://www.tfah.org/report-details/state-of-obesity-2022.
Nguồn: https://poissondistribution.lat
Danh mục: News
